The Management of ER-Low, HER2-Negative Breast Cancer in the United Kingdom: A Survey of Current Clinical Practice
There is marked variation in approach to ER-low in the UK. The audit data suggests treating ER-low BC as triple-negative BC.
Authors
- Ko‐Yung Sit (ORCID: https://orcid.org/0000-0001-6289-663X)
- Vasileios Angelis (ORCID: https://orcid.org/0009-0005-1395-0317)
- S. Atkinson
- Conor McCahill
- Kathryn Hawkesford
- Alison Berner (ORCID: https://orcid.org/0000-0002-1132-0275)
- Melissa Phillips (ORCID: https://orcid.org/0000-0003-0477-7637)
- Peter E. Hall (ORCID: https://orcid.org/0000-0002-0057-5985)
Institutions
- Queen Mary University of London (GB)
- Barts Health NHS Trust (GB)
Publication Details
- Journal
- Oncology and Therapy
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1007/s40487-025-00388-6
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00